DALLANOCE, CLELIA MARIANGIOLA LUISA
DALLANOCE, CLELIA MARIANGIOLA LUISA
Dipartimento di Scienze Farmaceutiche
M2-Receptor Stimulation in Blood-Brain-Tumour Barrier: Implications in Glioblastoma Therapy
2025 G. Scanavino, C. Guerriero, A. Roy, M. De Amici, C. Matera, C. Dallanoce, C. Mysiorek, M. Culot, A. Maria Tata
Binding and Dynamics of Dualsteric Agonists for M2R in Glioblastoma
2025 G. Scanavino, C. Metelli, C. Guerriero, M. Quarante, R. Matucci, S. Pascarella, C. Matera, M. De Amici, C. Dallanoce, A. Maria Tata
Sulfonium Moieties as Ammonium Bioisosteres: Novel Ligands for the Alpha7 Nicotinic Acetylcholine Receptor
2025 C. Papotto, C. Stokes, C. Matera, S.M. Herz, K. Chiang, R. Ferrisi, M. De Amici, M.I. Damaj, R.L. Papke, C. Dallanoce
Effects of Selective α7 Nicotinic Acetylcholine Receptor Stimulation in Oligodendrocytes: Putative Implication in Neuroinflammation
2025 C. Guerriero, G. Puliatti, T. Di Marino, G. Scanavino, C. Matera, C. Dallanoce, A.M. Tata
Light-Activated Pharmacological Tools for Exploring the Cholinergic System
2025 A. Colleoni, G. Galli, C. Dallanoce, M. De Amici, P. Gorostiza, C. Matera
Sulfonium compounds and methods for making and using the same
2024 R.L. Papke, C. Dallanoce, C. Papotto
Histidine containing dipeptides protect epithelial and endothelial cell barriers from methylglyoxal induced injury
2024 C. Wetzel, N. Gallenstein, V. Peters, T. Fleming, I. Marinovic, A. Bodenschatz, Z. Du, K. Küper, C. Dallanoce, G. Aldini, T. Schmoch, T. Brenner, M. Alexander Weigand, S.G. Zarogiannis, C. Peter Schmitt &, M. Bartosova
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold
2024 C. Dallanoce, K. Richter, C. Stokes, C. Papotto, H. Andleeb, G.A. Thakur, A. Kerr, V. Grau, R.L. Papke
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol
2024 F. Bianchi, E. Biganzoli, V. Bollati, M. Clerici, D. Lucini, C. Mando, F. Rota, F. Ambrogi, B. Arosio, M. Aureli, G. Baron, M. Baruscotti, C. Battaglia, C. Bellocchi, S. Bellosta, C. Bernardelli, G. Bernardelli, M. Bonomi, F. Bravi, P. Brocca, A.L. Brucato, A. Bucchi, M. Camera, N. Caporale, G. Cappelletti, L. Casati, S. Castaldi, S. Castiglioni, M.G. Cattaneo, R. Cazzola, S. Centanni, I. Cetin, R. Chiaramonte, I. Chiodini, E. Chiricozzi, P. Ciana, V. Citro, C.B. Cogliati, S.L. Corbetta, F. D'Addio, A. D'Amato, C.M.L. Dallanoce, M.V. Dei Cas, E. Del Favero, A. Delle Fave, G. Dias Rodrigues, V.C. Edefonti, C. Fenizia, L. Ferrari, M. Ferraroni, P. Fiorina, D.M.M. Fornasari, M. Fumagalli, N. Gagliano, E.R. Galliera, J.A.E. Geginat, D. Giannandrea, F.A. Ingegnoli, C.A.M. La Porta, C.V.B. La Vecchia, D. Lecca, E.A. Lesma, P. Limonta, C. Loretelli, V. Martini, C. Matera, N. Montano, L. Pantoni, N. Papini, R.C. Paroni, C. Perego, L. Persani, A.S. Pistocchi, N. Platonova, G. Podda, P.T. Rise', P.V. Riva, A.M. Rizzo, V.M. Rondelli, M. Rossi, M. Ruscica, V.M. Savasi, M. Scavone, L. Sfondrini, L. Sironi, M. Sommariva, G. Testa, E. Tobaldini, C.A. Tringali, E. Verduci, M. Vicenzi, C.A. Vigano', G. Vistoli, G. Vitale
A Photoactivatable Version of Ivabradine Enables Light-Induced Block of HCN Current In Vivo
2024 A. Porro, E. Armano, F. Brandalise, R. Appiani, M. Beltrame, A. Saponaro, C. Dallanoce, K. Nakajo, K. Ryu, R. Leone, G. Thiel, M. Pallavicini, A. Moroni, C. Bolchi
Interaction between M2 Muscarinic receptors and β-1 arrestin in gliblastoma cell lines: effects mediated by orthosteric and dualsteric agonists
2024 G. Scanavino, C. Guerriero, F. Frezza, M. Quaranta, F. Ottavi, S. Quaresima, G. Lupo, S. Pascarella, M. De Amici, C. Matera, C. Dallanoce, L. Rosanò, A.M. Tata
M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition
2024 C. Guerriero, M. Manfredelli, C. Matera, A. Iuzzolino, L. Conti, C. Dallanoce, M. De Amici, D. Trisciuoglio, A.M. Tata
Targeting the D3R-nAChR heteromeric complex for nicotine cessation
2023 V. Lallai, C. Matera, K. Bodinayake, C.M.L. Dallanoce, C. Fowler
Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation
2023 C. Matera, M. Kauk, D. Cirillo, M. Maspero, C. Papotto, D. Volpato, U. Holzgrabe, M. DE AMICI, C. Hoffmann, C.M.L. Dallanoce
Effects mediated by α7 nicotinic receptors activation in Schwann cells: implication in peripheral nerve regeneration
2023 C. Guerriero, E. Botticelli, M.S. Salazar Intriago, S. Fucile, M.E. De Stefano, C. Matera, M. De Amici, C. Dallanoce, R. Piovesana, A.M. Tata
M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition
2023 C. Guerriero, M. Manfredelli, C. Matera, A. Iuzzolino, L. Conti, C. Dallanoce, M. DE AMICI, D. Trisciuoglio, A. Maria Tata
α7 Nicotinic Acetylcholine Receptors May Improve Schwann Cell Regenerating Potential via Metabotropic Signaling Pathways
2023 E. Botticelli, C. Guerriero, S. Fucile, M. Egle De Stefano, C. Matera, C.M.L. Dallanoce, M. DE AMICI, A. Maria Tata
Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
2023 C. Matera, C. Papotto, C. Dallanoce, M. De Amici
Recent Advances in the Modulation of Cholinergic Signaling
2022 C. Dallanoce
Identification of novel potential B4GALT6 inhibitors through a large scale virtual screening
2022 C. Papotto, E. Sabato, D. Lecca, C. Matera, M. DE AMICI, A. Pedretti, C.M.L. Dallanoce, G. Vistoli